ALPHA Trial: ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma

1 Views
administrator
administrator
07/09/23

Sattva Neelapu, MD, University of Texas MD Anderson Cancer Center, Houston, TX, describes the Phase I study ALPHA study (NCT03939026), evaluating the safety and efficacy of ALLO-501. An anti-CD19 allogeneic CAR-T cell in adults with relapsed/refractory large B-cell or follicular lymphoma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Show more
0 Comments Sort By

    No comments found

    Facebook Comments

    Up next

    Aerang Kim - MR-HIFU for the ablation of relapsed or refractory pediatric solid tumors (2018)
    00:06:57
    Aerang Kim - MR-HIFU for the ablation of relapsed or refractory pediatric solid tumors (2018)
    administrator
    2 Views
    Episode 14 - Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results
    00:46:23
    Episode 14 - Ewing Sarcoma Phase 3 Clinical Trial - Discussing The Results
    administrator
    3 Views
    Cancer ‘cured’ in all patients in drug trial, Indian origin patient healed
    00:05:44
    Cancer ‘cured’ in all patients in drug trial, Indian origin patient healed
    administrator
    2 Views
    BroMac Trial: US perspective: Dr. Edward Levine, Chief of Surgical Oncology, Wake Forest
    00:11:41
    BroMac Trial: US perspective: Dr. Edward Levine, Chief of Surgical Oncology, Wake Forest
    administrator
    1 Views
    BroMac Trial: US perspective: Dr. Edward Levine, Chief of Surgical Oncology, Wake Forest
    00:11:41
    BroMac Trial: US perspective: Dr. Edward Levine, Chief of Surgical Oncology, Wake Forest
    administrator
    0 Views
    Cutaneous Lymphoma Treatment Series - Video 4: Systemic Therapies
    00:05:59
    Cutaneous Lymphoma Treatment Series - Video 4: Systemic Therapies
    administrator
    4 Views
    Answers from the Experts: Pathology of Cutaneous Lymphoma
    00:51:04
    Answers from the Experts: Pathology of Cutaneous Lymphoma
    administrator
    14 Views
    Dos and Don'ts Cutaneous T Cell Lymphoma - a type of blood cancer
    00:05:30
    Dos and Don'ts Cutaneous T Cell Lymphoma - a type of blood cancer
    administrator
    6 Views
    T-Cell Lymphoma with Barbara Pro, MD | Everything You Need to Know
    00:07:31
    T-Cell Lymphoma with Barbara Pro, MD | Everything You Need to Know
    administrator
    4 Views
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - CD30+lymphoproliferations
    00:37:15
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - CD30+lymphoproliferations
    administrator
    5 Views
    Meet Michelle: T-Cell Lymphoma Survivor
    00:04:15
    Meet Michelle: T-Cell Lymphoma Survivor
    administrator
    3 Views
    #Cutaneous T cell lymphoma #PET/CT
    00:00:09
    #Cutaneous T cell lymphoma #PET/CT
    administrator
    1 Views
    Cutaneous Lymphoma Catalyst Research Grant Recipients
    00:12:19
    Cutaneous Lymphoma Catalyst Research Grant Recipients
    administrator
    5 Views
    Treatments Cutaneous T Cell Lymphoma - a type of blood cancer
    00:05:47
    Treatments Cutaneous T Cell Lymphoma - a type of blood cancer
    administrator
    2 Views
    Future directions for checkpoint inhibitors in cutaneous lymphoma treatment
    00:01:35
    Future directions for checkpoint inhibitors in cutaneous lymphoma treatment
    administrator
    2 Views
    Doc Talk: Cutaneous Lymphoma
    00:00:58
    Doc Talk: Cutaneous Lymphoma
    administrator
    3 Views
    Answers from the Experts: Cutaneous B-Cell Lymphoma Variants
    00:04:41
    Answers from the Experts: Cutaneous B-Cell Lymphoma Variants
    administrator
    3 Views
    CD30+ cutaneous T-cell lymphoma (Medical Condition)
    00:00:39
    CD30+ cutaneous T-cell lymphoma (Medical Condition)
    administrator
    5 Views
    T-cell Lymphoma
    00:19:42
    T-cell Lymphoma
    administrator
    6 Views